Clinical trial NCT02230449: Identifying Expression Markers of Cumulus Cells to Identify Oocyte Developmental Potential Through a Maturation Analysis
Official title: Identifying Markers of Oocyte Competence Through a Maturation Analysis
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Infertility
Lead sponsor: Memorial Sisli Hospital, Istanbul
Sponsor class: OTHER
First posted: 2014-09-03
Enrollment: 200
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 39
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Infertile couples applying to the clinic for assisted reproductive technologies

Brief summary: The aim of the study is to analyze the expression of genes and microRNAs potentially involved in oocyte competence in follicles of different sizes (\<17mm and ≥17mm) at the time of oocyte pick-up.

Detailed description: In ART, one of the major obstacles encountered in some patients is the wide variation in the follicular size at the oocyte pick-up day and consequently, the number of available mature oocytes and the number of competent embryos for implantation. The follicular size at the day of oocyte pick-up reflects the synchronicity of the individual follicular responsiveness to FSH.

For successful preimplantation development of an embryo, the oocyte must contain all necessary maternal factors. Two of these factors are specific mRNA transcripts (GDF9, PTX3, HAS2, PTGS2, TNFAIP6) and microRNA (miR-224).

For each Cumulus Oocyte Complex, the evaluation of embryo development and morphokinetics will be correlated with the expression and implantation data to identify a quantitative biomarker to predict the embryo with the highest chance of implantation in patients.

Experimental Design:

1. - Collection of Cumulus Oocyte Complex (COC) from patients
2. - Separation of oocytes according to the size of the follicule they have been retrieved from (\<17mm; ≥17mm)
3. - Isolation of mRNA from both groups of cumulus cells
4. - Expression studies, qRT-PCR (GDF9, PTX3, HAS2, PTGS2, TNFAIP6)
5. - Analysis of miR-224, a negative regulator of cumulus expansion via PTX3
6. - Time-lapse culture \& evaluation of morphokinetics

Eligibility criteria: Inclusion Criteria:

* No more than 2 previous treatment cycles
* No history of recurrent spontaneous abortions
* Age ≤ 39 years
* BMI \< 30 kg / m2
* ≥ 8 cumulus-oocyte-complexes (COC) retrieved
* human Chorionic Gonadotrophin (hCG) triggering

Exclusion Criteria:

* Preimplantaion Genetic Diagnosis (PGD) or Preimplantation Genetics Screening (PGS) indication
* Maximum number of 24 COC during pickup
* Failure to culture until Day 5
* Polycystic ovary syndrome
* Severe endometrial factor that can influence implantation
* Uterine malformation or congenital anomaly
* Severe male factor (Azoospermia)

Primary outcomes:
measure: Cumulus cell RNA expression correlation with blastocyst formation potential and quality
timeFrame: 6 days
Secondary outcomes:
measure: Implantation Rate
timeFrame: 2 months
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Memorial Sisli Hospital ART Center
Study officials:
affiliation: Manager of ART and Genetics Center
name: Semra Kahraman, Prof. Dr
role: STUDY_CHAIR
affiliation: Manager of ART and Genetics Center
name: Semra Kahraman, Prof. Dr.
role: STUDY_DIRECTOR
affiliation: ART Center Research and Development Department
name: Mehmet Ali Tufekci, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Kahraman S, Cetinkaya CP, Cetinkaya M, Tufekci MA, Ekmekci CG, Montag M. Is there a correlation between follicle size and gene expression in cumulus cells and is gene expression an indicator of embryo development? Reprod Biol Endocrinol. 2018 Jul 21;16(1):69. doi: 10.1186/s12958-018-0388-0.